CoreCap Advisors’s Delcath Systems DCTH Stock Holding History

CoreCap Advisors’s Portfolio DCTH Stock Details DCTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-300	Closed	-$4.08K	–	2822
2025 Q2	$4.08K	Buy	+300	New	+$4.18K	﹤0.01%	2159

Other funds holding DCTH

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

CoreCap Advisors's DCTH Position: Q3 2025 in Review

CoreCap Advisors sold out of Delcath Systems (DCTH) in Q3 2025, closing a stake of 300 shares — an estimated $4.08K sold.

CoreCap Advisors first reported a position in DCTH in Q2 2025 and held it in 1 quarter. The position peaked at $4.08K in Q2 2025. 124 funds tracked by Wall St. Rank hold DCTH as of Q3 2025.

CoreCap Advisors reported no remaining Delcath Systems position as of Q3 2025 after selling out during the quarter.
CoreCap Advisors sold 300 Delcath Systems shares in Q3 2025, an estimated $4.08K.
CoreCap Advisors first reported a position in Delcath Systems in Q2 2025 and held it in 1 quarter.
CoreCap Advisors's Delcath Systems position peaked at $4.08K in Q2 2025.
124 funds tracked by Wall St. Rank held Delcath Systems as of Q3 2025.

Based on CoreCap Advisors's 13F filing for Q3 2025, filed 22 Oct 2025.